Logo image
SPON1 Is associated with Amyloid-β and APOE ε4-Related cognitive decline in cognitively normal adults
Journal article   Open access   Peer reviewed

SPON1 Is associated with Amyloid-β and APOE ε4-Related cognitive decline in cognitively normal adults

S. Fernandez, S.C. Burnham, L. Milicic, G. Savage, P. Maruff, M. Peretti, H.R. Sohrabi, Y.Y. Lim, M. Weinborn, D. Ames, …
Journal of Alzheimer's Disease Reports, Vol.5(1), pp.111-120
2021
pdf
SPON1.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Background: Genetic variation in Spondin-1, specifically rs11023139, has been associated with reduced rates of cognitive decline in individuals with Alzheimer’s disease. Objective: The aim of this study was to assess whether the association was present in cognitively normal older adults. Methods: Longitudinal cognitive decline was investigated using linear mixed modelling in a cohort of 590 cognitively normal older adults enrolled in the Australian Imaging, Biomarkers and Lifestyle Study. Results: No independent effect of Spondin-1 rs11023139 on cognitive decline was observed. However, significant associations were observed for the interaction between Apolipoprotein E (APOE) ɛ4 and rs11023139 in individuals with high amyloid-β burden. APOE ɛ4/rs11023139-A carriers declined significantly faster than APOE ɛ4/rs11023139-G_G carriers in measures of global cognition (p = 0.011) and verbal episodic memory (p = 0.020). Conclusion: These results suggest that carriage of the Spondin-1 rs11023139-A allele significantly contributes to a worsening of cognitive performance in APOE ɛ4 cognitively normal older adults with a high neocortical amyloid-β burden.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

18 File views/ downloads
35 Record Views
Logo image